Publizoom

ASTRAZENECA- PROD.FARM LDA

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
9
Amount won alone
€4,986,567 excl. VAT
Period
28 July 2026 – 20 October 2026

Its main clients

Where and what

Supplies · 9

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
10 December 2026
re-tender around October 2026
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€232,935
23 December 2026
re-tender around October 2026
2026/0006 - Olaparib [150 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€266,176
23 December 2026
re-tender around October 2026
2023/0491 - Osimertinib [80 mg comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€2,221,439
23 December 2026
re-tender around October 2026
2023/0492 - Durvalumab [50 mg/ ml 10 ml frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€684,601
23 December 2026
re-tender around October 2026
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€229,116
23 December 2026
re-tender around October 2026
2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€613,531
25 December 2026
re-tender around October 2026
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€305,488
27 December 2026
re-tender around October 2026
2023/0492 - Durvalumab [50 mg/ ml 10 ml frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€295,511
28 December 2026
re-tender around October 2026
2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
ASTRAZENECA- PROD.FARM LDA
1 bid received
€137,769

Contracts won

DateContractBuyerAmount
20/10/2026 2026/0006 - Olaparib [150 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. €266,176
08/09/2026 2025/1303 - Acalabrutinib [100 mg cáp/comp] Unidade Local de Saúde Santa Maria, E.P.E. €305,488
08/09/2026 2025/1303 - Acalabrutinib [100 mg cáp/comp] Unidade Local de Saúde Santa Maria, E.P.E. €229,116
08/09/2026 2025/1303 - Acalabrutinib [100 mg cáp/comp] Unidade Local de Saúde Santa Maria, E.P.E. €232,935
08/09/2026 2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa] Unidade Local de Saúde Santa Maria, E.P.E. €613,531
08/09/2026 2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa] Unidade Local de Saúde Santa Maria, E.P.E. €137,769
11/08/2026 2023/0492 - Durvalumab [50 mg/ ml 10 ml frs] Unidade Local de Saúde Santa Maria, E.P.E. €295,511
11/08/2026 2023/0492 - Durvalumab [50 mg/ ml 10 ml frs] Unidade Local de Saúde Santa Maria, E.P.E. €684,601
28/07/2026 2023/0491 - Osimertinib [80 mg comp] Unidade Local de Saúde Santa Maria, E.P.E. €2,221,439

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.